Bombay HC Grants Interim Relief To Glenmark In Trademark ‘Alex’ Dispute

Mumbai : The Bombay High Court has restrained herbal product maker Alex World Class Products Pvt Ltd from using the trademark ‘Alex’ for its product and directed the Jaipur-based company to hand over the domain name to Glenmark Pharmaceuticals Ltd, until further orders.

The court posted the matter for further hearing on December 5.

“This court is convinced that in the light of the position of law and the material brought to the notice of this court, a strong prima facie case is made out by the plaintiff (Glenmark) and if the ad-interim reliefs, as claimed, are not granted at this stage, the plaintiff will continue to suffer irreparable loss,” Justice Manish Pitale observed in a seven-page order.

Advocate Hiren Kamod, who appeared on behalf of Glenmark, argued that the company had been using the trademark since 1990 and that there were as many as nine registrations in its favour.

Glenmark also submitted that the first registration was dated June 14, 1988, even as the herbal product maker was incorporated only in 2018.

The Mumbai-based listed pharmaceutical firm also said its revenue from the brand was about Rs 108 crore during financial year 2021-22 and that the company had spent a substantial amount in sales promotion of the ‘Alex’ brand products, including cough syrups and lozenges.

“The sales figure was brought to the notice of this Court, which shows the extent of goodwill of the product of the plaintiff in the market, and it clearly shows that use of the mark ‘Alex’ on the products of the defendants would have the tendency of giving unfair advantage to the defendants,” the court said in its order on October 20.

In February 2021, Glenmark came across the similarly named products and issued a cease-and-desist notice to the Jaipur-based company on March 19 of that year.

However, in its response to the notice, the respondent (Alex World Class Products) claimed that its products were ayurvedic and herbal as opposed to the pharmaceutical ones of the Glenn Saldanha-promoted company.

The herbal-product maker’s argument – that the word ‘Alex’ is a house mark – is not sustainable, since it clearly infringed upon its registered trademark, Glenmark argued.

Under intellectual property rights law, a house mark refers to the trademark that a company uses to identify its commercial operations.

Related Posts

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week. Argentina has committed to reduce barriers to facilitate the entry of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers